Username

Password

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Douglas Lowy

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Living Beings

Anatomy

Chemicals & Drugs

Physiology

Disorders

Genes & Molecular Sequences

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Qian Xiaolan; Li Guorong; Vass William C; Papageorge Alex; Walker Renard C; Asnaghi Laura; Steinbach Peter J; Tosato Giovanna; Hunter Kent; Lowy Douglas R
The Tensin-3 protein, including its SH2 domain, is phosphorylated by Src and contributes to tumorigenesis and metastasis.
Schiller John T; Lowy Douglas R
Immunogenicity testing in human papillomavirus virus-like-particle vaccine trials.
Jagu Subhashini; Karanam Balasubramanyam; Gambhira Ratish; Chivukula Sudha V; Chaganti Revathi J; Lowy Douglas R; Schiller John T; Roden Richard B S
Concatenated multitype L2 fusion proteins as candidate prophylactic pan-human papillomavirus vaccines.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Douglas Lowy (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Qian Xiaolan; Li Guorong; Vass William C; Papageorge Alex; Walker Renard C; Asnaghi Laura; Steinbach Peter J; Tosato Giovanna; Hunter Kent; Lowy Douglas R
The Tensin-3 protein, including its SH2 domain, is phosphorylated by Src and contributes to tumorigenesis and metastasis.
Cancer cell 2009;16(3):246-58.
2009: Schiller John T; Lowy Douglas R
Immunogenicity testing in human papillomavirus virus-like-particle vaccine trials.
The Journal of infectious diseases 2009;200(2):166-71.
2009: Jagu Subhashini; Karanam Balasubramanyam; Gambhira Ratish; Chivukula Sudha V; Chaganti Revathi J; Lowy Douglas R; Schiller John T; Roden Richard B S
Concatenated multitype L2 fusion proteins as candidate prophylactic pan-human papillomavirus vaccines.
Journal of the National Cancer Institute 2009;101(11):782-92.
2009: Yang X-Y; Guan M; Vigil D; Der C J; Lowy D R; Popescu N C
p120Ras-GAP binds the DLC1 Rho-GAP tumor suppressor protein and inhibits its RhoA GTPase and growth-suppressing activities.
Oncogene 2009;28(11):1401-9.
2009: Johnson Katherine M; Kines Rhonda C; Roberts Jeffrey N; Lowy Douglas R; Schiller John T; Day Patricia M
Role of heparan sulfate in attachment to and infection of the murine female genital tract by human papillomavirus.
Journal of virology 2009;83(5):2067-74.
2009: García-Piñeres Alfonso J; Hildesheim Allan; Dodd Lori; Kemp Troy J; Yang Jun; Fullmer Brandie; Harro Clayton; Lowy Douglas R; Lempicki Richard A; Pinto Ligia A
Gene expression patterns induced by HPV-16 L1 virus-like particles in leukocytes from vaccine recipients.
Journal of immunology (Baltimore, Md. : 1950) 2009;182(3):1706-29.
2009: Buck Christopher B; Lowy Douglas R
Getting stronger: the relationship between a newly identified virus and Merkel cell carcinoma.
The Journal of investigative dermatology 2009;129(1):9-11.
2008: Day Patricia M; Lowy Douglas R; Schiller John T
Heparan sulfate-independent cell binding and infection with furin-precleaved papillomavirus capsids.
Journal of virology 2008;82(24):12565-8.
2008: Gillison Maura L; Chaturvedi Anil K; Lowy Douglas R
HPV prophylactic vaccines and the potential prevention of noncervical cancers in both men and women.
Cancer 2008;113(10 Suppl):3036-46.
2008: Lowy Douglas R; Solomon Diane; Hildesheim Allan; Schiller John T; Schiffman Mark
Human papillomavirus infection and the primary and secondary prevention of cervical cancer.
Cancer 2008;113(7 Suppl):1980-93.
2008: Herrero Rolando; Hildesheim Allan; Rodríguez Ana C; Wacholder Sholom; Bratti Concepción; Solomon Diane; González Paula; Porras Carolina; Jiménez Silvia; Guillen Diego; Morales Jorge; Alfaro Mario; Cyr Jean; Morrisey Kerrygrace; Estrada Yenory; Cortés Bernal; Morera Lidia Ana; Freer Enrique; Schussler John; Schiller John; Lowy Douglas; Schiffman Mark;
Rationale and design of a community-based double-blind randomized clinical trial of an HPV 16 and 18 vaccine in Guanacaste, Costa Rica.
Vaccine 2008;26(37):4795-808.
2008: Lowy Doug
Human papillomavirus, cervical cancer prevention, and more.
Vaccine 2008;26 Suppl 10():iii-iv.
2008: Buck Christopher B; Cheng Naiqian; Thompson Cynthia D; Lowy Douglas R; Steven Alasdair C; Schiller John T; Trus Benes L
Arrangement of L2 within the papillomavirus capsid.
Journal of virology 2008;82(11):5190-7.
2008: Day Patricia M; Gambhira Ratish; Roden Richard B S; Lowy Douglas R; Schiller John T
Mechanisms of human papillomavirus type 16 neutralization by l2 cross-neutralizing and l1 type-specific antibodies.
Journal of virology 2008;82(9):4638-46.
2008: Kemp Troy J; Hildesheim Allan; Falk Roni T; Schiller John T; Lowy Douglas R; Rodriguez Ana Cecilia; Pinto Ligia A
Evaluation of two types of sponges used to collect cervical secretions and assessment of antibody extraction protocols for recovery of neutralizing anti-human papillomavirus type 16 antibodies.
Clinical and vaccine immunology : CVI 2008;15(1):60-4.
2007: Crawford Nigel P S; Qian Xiaolan; Ziogas Argyrios; Papageorge Alex G; Boersma Brenda J; Walker Renard C; Lukes Luanne; Rowe William L; Zhang Jinghui; Ambs Stefan; Lowy Douglas R; Anton-Culver Hoda; Hunter Kent W
Rrp1b, a new candidate susceptibility gene for breast cancer progression and metastasis.
PLoS genetics 2007;3(11):e214.
2007: Frazer Ian H; Lowy Doug R; Schiller John T
Prevention of cancer through immunization: Prospects and challenges for the 21st century.
European journal of immunology 2007;37 Suppl 1():S148-55.
2007: Durkin Marian E; Yuan Bao-Zhu; Zhou Xiaoling; Zimonjic Drazen B; Lowy Douglas R; Thorgeirsson Snorri S; Popescu Nicholas C
DLC-1:a Rho GTPase-activating protein and tumour suppressor.
Journal of cellular and molecular medicine 2007;11(5):1185-207.
2007: Lowy Douglas R
Aaron Lerner: a mentor and friend.
The Journal of investigative dermatology 2007;127(9):2092.
2007: Hildesheim Allan; Herrero Rolando; Wacholder Sholom; Rodriguez Ana C; Solomon Diane; Bratti M Concepcion; Schiller John T; Gonzalez Paula; Dubin Gary; Porras Carolina; Jimenez Silvia E; Lowy Douglas R;
Effect of human papillomavirus 16/18 L1 viruslike particle vaccine among young women with preexisting infection: a randomized trial.
JAMA : the journal of the American Medical Association 2007;298(7):743-53.
2007: García-Piñeres Alfonso; Hildesheim Allan; Dodd Lori; Kemp Troy J; Williams Marcus; Harro Clayton; Lowy Douglas R; Schiller John T; Pinto Ligia A
Cytokine and chemokine profiles following vaccination with human papillomavirus type 16 L1 Virus-like particles.
Clinical and vaccine immunology : CVI 2007;14(8):984-9.
2007: Day Patricia M; Thompson Cynthia D; Buck Christopher B; Pang Yuk-Ying S; Lowy Douglas R; Schiller John T
Neutralization of human papillomavirus with monoclonal antibodies reveals different mechanisms of inhibition.
Journal of virology 2007;81(16):8784-92.
2007: Roberts Jeffrey N; Buck Christopher B; Thompson Cynthia D; Kines Rhonda; Bernardo Marcelino; Choyke Peter L; Lowy Douglas R; Schiller John T
Genital transmission of HPV in a mouse model is potentiated by nonoxynol-9 and inhibited by carrageenan.
Nature medicine 2007;13(7):857-61.
2007: Qian Xiaolan; Li Guorong; Asmussen Holly K; Asnaghi Laura; Vass William C; Braverman Richard; Yamada Kenneth M; Popescu Nicholas C; Papageorge Alex G; Lowy Douglas R
Oncogenic inhibition by a deleted in liver cancer gene requires cooperation between tensin binding and Rho-specific GTPase-activating protein activities.
Proceedings of the National Academy of Sciences of the United States of America 2007;104(21):9012-7.
2006: Schiller John T; Lowy Douglas R
Prospects for cervical cancer prevention by human papillomavirus vaccination.
Cancer research 2006;66(21):10229-32.
2006: Pinto Ligia A; Viscidi Raphael; Harro Clayton D; Kemp Troy J; García-Piñeres Alfonso J; Trivett Matthew; Demuth Franklin; Lowy Douglas R; Schiller John T; Berzofsky Jay A; Hildesheim Allan
Cellular immune responses to HPV-18, -31, and -53 in healthy volunteers immunized with recombinant HPV-16 L1 virus-like particles.
Virology 2006;353(2):451-62.
2006: Stanley Margaret; Lowy Douglas R; Frazer Ian
Chapter 12: Prophylactic HPV vaccines: underlying mechanisms.
Vaccine 2006;24 Suppl 3():S3/106-13.
2006: Buck Christopher B; Thompson Cynthia D; Roberts Jeffrey N; Müller Martin; Lowy Douglas R; Schiller John T
Carrageenan is a potent inhibitor of papillomavirus infection.
PLoS pathogens 2006;2(7):e69.
2006: Lowy Douglas R; Schiller John T
Prophylactic human papillomavirus vaccines.
The Journal of clinical investigation 2006;116(5):1167-73.
2006: Buck Christopher B; Day Patricia M; Thompson Cynthia D; Lubkowski Jacek; Lu Wuyuan; Lowy Douglas R; Schiller John T
Human alpha-defensins block papillomavirus infection.
Proceedings of the National Academy of Sciences of the United States of America 2006;103(5):1516-21.
2006: Richards Rebecca M; Lowy Douglas R; Schiller John T; Day Patricia M
Cleavage of the papillomavirus minor capsid protein, L2, at a furin consensus site is necessary for infection.
Proceedings of the National Academy of Sciences of the United States of America 2006;103(5):1522-7.
2005: Park Yeong-Gwan; Zhao Xiaohong; Lesueur Fabienne; Lowy Douglas R; Lancaster Mindy; Pharoah Paul; Qian Xiaolan; Hunter Kent W
Sipa1 is a candidate for underlying the metastasis efficiency modifier locus Mtes1.
Nature genetics 2005;37(10):1055-62.
2005: Pastrana Diana V; Gambhira Ratish; Buck Christopher B; Pang Yuk-Ying S; Thompson Cynthia D; Culp Timothy D; Christensen Neil D; Lowy Douglas R; Schiller John T; Roden Richard B S
Cross-neutralization of cutaneous and mucosal Papillomavirus types with anti-sera to the amino terminus of L2.
Virology 2005;337(2):365-72.
2005: Nardelli-Haefliger Denise; Lurati Floriana; Wirthner Daniel; Spertini François; Schiller John T; Lowy Douglas R; Ponci Françoise; De Grandi Pierre
Immune responses induced by lower airway mucosal immunisation with a human papillomavirus type 16 virus-like particle vaccine.
Vaccine 2005;23(28):3634-41.
2005: Pinto Ligia A; Castle Philip E; Roden Richard B; Harro Clayton D; Lowy Douglas R; Schiller John T; Wallace Dora; Williams Marcus; Kopp William; Frazer Ian H; Berzofsky Jay A; Hildesheim Allan
HPV-16 L1 VLP vaccine elicits a broad-spectrum of cytokine responses in whole blood.
Vaccine 2005;23(27):3555-64.
2005: Lenz Petra; Lowy Douglas R; Schiller John T
Papillomavirus virus-like particles induce cytokines characteristic of innate immune responses in plasmacytoid dendritic cells.
European journal of immunology 2005;35(5):1548-56.
2005: Buck Christopher B; Thompson Cynthia D; Pang Yuk-Ying S; Lowy Douglas R; Schiller John T
Maturation of papillomavirus capsids.
Journal of virology 2005;79(5):2839-46.
2005: Buck Christopher B; Pastrana Diana V; Lowy Douglas R; Schiller John T
Generation of HPV pseudovirions using transfection and their use in neutralization assays.
Methods in molecular medicine 2005;119():445-62.
2004: Day Patricia M; Baker Carl C; Lowy Douglas R; Schiller John T
Establishment of papillomavirus infection is enhanced by promyelocytic leukemia protein (PML) expression.
Proceedings of the National Academy of Sciences of the United States of America 2004;101(39):14252-7.
2004: Gillison M L; Lowy D R
A causal role for human papillomavirus in head and neck cancer.
Lancet 2004;363(9420):1488-9.
2004: Qian Xiaolan; Karpova Tatiana; Sheppard Allan M; McNally James; Lowy Douglas R
E-cadherin-mediated adhesion inhibits ligand-dependent activation of diverse receptor tyrosine kinases.
The EMBO journal 2004;23(8):1739-48.
2004: Pastrana Diana V; Buck Christopher B; Pang Yuk-Ying S; Thompson Cynthia D; Castle Philip E; FitzGerald Peter C; Krüger Kjaer Susanne; Lowy Douglas R; Schiller John T
Reactivity of human sera in a sensitive, high-throughput pseudovirus-based papillomavirus neutralization assay for HPV16 and HPV18.
Virology 2004;321(2):205-16.
2004: Chackerian Bryce; Briglio Lindsey; Albert Paul S; Lowy Douglas R; Schiller John T
Induction of autoantibodies to CCR5 in macaques and subsequent effects upon challenge with an R5-tropic simian/human immunodeficiency virus.
Journal of virology 2004;78(8):4037-47.
2004: Buck Christopher B; Pastrana Diana V; Lowy Douglas R; Schiller John T
Efficient intracellular assembly of papillomaviral vectors.
Journal of virology 2004;78(2):751-7.
2003: Bliskovsky Valery; Ramsay Edward S; Scott John; DuBois Wendy; Shi Wei; Zhang Shuling; Qian Xiaolan; Lowy Douglas R; Mock Beverly A
Frap, FKBP12 rapamycin-associated protein, is a candidate gene for the plasmacytoma resistance locus Pctr2 and can act as a tumor suppressor gene.
Proceedings of the National Academy of Sciences of the United States of America 2003;100(25):14982-7.
2003: Lowy Douglas R; Gillison Maura L
A new link between Fanconi anemia and human papillomavirus-associated malignancies.
Journal of the National Cancer Institute 2003;95(22):1648-50.
2003: Nardelli-Haefliger Denise; Wirthner Daniel; Schiller John T; Lowy Douglas R; Hildesheim Allan; Ponci Françoise; De Grandi Pierre
Specific antibody levels at the cervix during the menstrual cycle of women vaccinated with human papillomavirus 16 virus-like particles.
Journal of the National Cancer Institute 2003;95(15):1128-37.
2003: Pinto Ligia A; Edwards Jessica; Castle Philip E; Harro Clayton D; Lowy Douglas R; Schiller John T; Wallace Dora; Kopp William; Adelsberger Joseph W; Baseler Michael W; Berzofsky Jay A; Hildesheim Allan
Cellular immune responses to human papillomavirus (HPV)-16 L1 in healthy volunteers immunized with recombinant HPV-16 L1 virus-like particles.
The Journal of infectious diseases 2003;188(2):327-38.
2003: Li Shaowei; Braverman Richard; Li Hongzhen; Vass William C; Lowy Douglas R; DeClue Jeffrey E
Regulation of cell morphology and adhesion by the tuberous sclerosis complex (TSC1/2) gene products in human kidney epithelial cells through increased E-cadherin/beta-catenin activity.
Molecular carcinogenesis 2003;37(2):98-109.
2003: Zhang Shuling; Qian Xiaolan; Redman Chanelle; Bliskovski Valeri; Ramsay Edward S; Lowy Douglas R; Mock Beverly A
p16 INK4a gene promoter variation and differential binding of a repressor, the ras-responsive zinc-finger transcription factor, RREB.
Oncogene 2003;22(15):2285-95.
2003: Lenz Petra; Thompson Cynthia D; Day Patricia M; Bacot Silvia M; Lowy Douglas R; Schiller John T
Interaction of papillomavirus virus-like particles with human myeloid antigen-presenting cells.
Clinical immunology (Orlando, Fla.) 2003;106(3):231-7.
2003: Day Patricia M; Lowy Douglas R; Schiller John T
Papillomaviruses infect cells via a clathrin-dependent pathway.
Virology 2003;307(1):1-11.
2003: Lowy Douglas R; Frazer Ian H
Chapter 16: Prophylactic human papillomavirus vaccines.
Journal of the National Cancer Institute. Monographs 2003;(31):111-6.
2002: Chackerian Bryce; Lenz Petra; Lowy Douglas R; Schiller John T
Determinants of autoantibody induction by conjugated papillomavirus virus-like particles.
Journal of immunology (Baltimore, Md. : 1950) 2002;169(11):6120-6.
2001: Roden R B; Day P M; Bronzo B K; Yutzy W H; Yang Y; Lowy D R; Schiller J T
Positively charged termini of the L2 minor capsid protein are necessary for papillomavirus infection.
Journal of virology 2001;75(21):10493-7.
2001: Bosch F X; Muñoz N; de Sanjosé S; Franco E L; Lowy D R; Schiffman M; Franceschi S; Kjaer S K; Meijer C J; Frazer I H; Cuzick J
Re: Cervical carcinoma and human papillomavirus: on the road to preventing a major human cancer.
Journal of the National Cancer Institute 2001;93(17):1349-50.
2001: Chackerian B; Lowy D R; Schiller J T
Conjugation of a self-antigen to papillomavirus-like particles allows for efficient induction of protective autoantibodies.
The Journal of clinical investigation 2001;108(3):415-23.
2001: Schiller J T; Lowy D R
Papillomavirus-like particle based vaccines: cervical cancer and beyond.
Expert opinion on biological therapy 2001;1(4):571-81.
2001: Lenz P; Day P M; Pang Y Y; Frye S A; Jensen P N; Lowy D R; Schiller J T
Papillomavirus-like particles induce acute activation of dendritic cells.
Journal of immunology (Baltimore, Md. : 1950) 2001;166(9):5346-55.
2001: Okun M M; Day P M; Greenstone H L; Booy F P; Lowy D R; Schiller J T; Roden R B
L1 interaction domains of papillomavirus l2 necessary for viral genome encapsidation.
Journal of virology 2001;75(9):4332-42.
2001: Kjaer S K; Chackerian B; van den Brule A J; Svare E I; Paull G; Walbomers J M; Schiller J T; Bock J E; Sherman M E; Lowy D R; Meijer C L
High-risk human papillomavirus is sexually transmitted: evidence from a follow-up study of virgins starting sexual activity (intercourse).
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2001;10(2):101-6.
2001: Harro C D; Pang Y Y; Roden R B; Hildesheim A; Wang Z; Reynolds M J; Mast T C; Robinson R; Murphy B R; Karron R A; Dillner J; Schiller J T; Lowy D R
Safety and immunogenicity trial in adult volunteers of a human papillomavirus 16 L1 virus-like particle vaccine.
Journal of the National Cancer Institute 2001;93(4):284-92.
2001: Pastrana D V; Vass W C; Lowy D R; Schiller J T
NHPV16 VLP vaccine induces human antibodies that neutralize divergent variants of HPV16.
Virology 2001;279(1):361-9.
2001: Schiller J T; Lowy D R
Papillomavirus-like particle vaccines.
Journal of the National Cancer Institute. Monographs 2001;(28):50-4.
2000: Roden R B; Yutzy W H; Fallon R; Inglis S; Lowy D R; Schiller J T
Minor capsid protein of human genital papillomaviruses contains subdominant, cross-neutralizing epitopes.
Virology 2000;270(2):254-7.
2000: Qian X; Esteban L; Vass W C; Upadhyaya C; Papageorge A G; Yienger K; Ward J M; Lowy D R; Santos E
The Sos1 and Sos2 Ras-specific exchange factors: differences in placental expression and signaling properties.
The EMBO journal 2000;19(4):642-54.
1999: Anborgh P H; Qian X; Papageorge A G; Vass W C; DeClue J E; Lowy D R
Ras-specific exchange factor GRF: oligomerization through its Dbl homology domain and calcium-dependent activation of Raf.
Molecular and cellular biology 1999;19(7):4611-22.
1999: Chackerian B; Lowy D R; Schiller J T
Induction of autoantibodies to mouse CCR5 with recombinant papillomavirus particles.
Proceedings of the National Academy of Sciences of the United States of America 1999;96(5):2373-8.
1999: Lowy D R; Schiller J T
Papillomaviruses: prophylactic vaccine prospects.
Biochimica et biophysica acta 1999;1423(1):M1-8.
1998: De Bruijn M L; Greenstone H L; Vermeulen H; Melief C J; Lowy D R; Schiller J T; Kast W M
L1-specific protection from tumor challenge elicited by HPV16 virus-like particles.
Virology 1998;250(2):371-6.
1998: Greenstone H L; Nieland J D; de Visser K E; De Bruijn M L; Kirnbauer R; Roden R B; Lowy D R; Kast W M; Schiller J T
Chimeric papillomavirus virus-like particles elicit antitumor immunity against the E7 oncoprotein in an HPV16 tumor model.
Proceedings of the National Academy of Sciences of the United States of America 1998;95(4):1800-5.
1998: Qian X; Vass W C; Papageorge A G; Anborgh P H; Lowy D R
N terminus of Sos1 Ras exchange factor: critical roles for the Dbl and pleckstrin homology domains.
Molecular and cellular biology 1998;18(2):771-8.
1998: Day P M; Roden R B; Lowy D R; Schiller J T
The papillomavirus minor capsid protein, L2, induces localization of the major capsid protein, L1, and the viral transcription/replication protein, E2, to PML oncogenic domains.
Journal of virology 1998;72(1):142-50.
1998: Lowy D R; Schiller J T
Papillomaviruses and cervical cancer: pathogenesis and vaccine development.
Journal of the National Cancer Institute. Monographs 1998;(23):27-30.
1997: Nielsen K H; Papageorge A G; Vass W C; Willumsen B M; Lowy D R
The Ras-specific exchange factors mouse Sos1 (mSos1) and mSos2 are regulated differently: mSos2 contains ubiquitination signals absent in mSos1.
Molecular and cellular biology 1997;17(12):7132-8.
1997: Roden R B; Lowy D R; Schiller J T
Papillomavirus is resistant to desiccation.
The Journal of infectious diseases 1997;176(4):1076-9.
1997: Svare E I; Kjaer S K; Nonnenmacher B; Worm A M; Moi H; Christensen R B; van den Brule A J; Walboomers J M; Meijer C J; Hubbert N L; Lowy D R; Schiller J T
Seroreactivity to human papillomavirus type 16 virus-like particles is lower in high-risk men than in high-risk women.
The Journal of infectious diseases 1997;176(4):876-83.
1997: Roden R B; Armstrong A; Haderer P; Christensen N D; Hubbert N L; Lowy D R; Schiller J T; Kirnbauer R
Characterization of a human papillomavirus type 16 variant-dependent neutralizing epitope.
Journal of virology 1997;71(8):6247-52.
1997: Lowy D R
HPV infection: future prospects.
Clinics in dermatology 1997;15(2):299-302.
1997: Ferrier A F; Lee M; Anderson W B; Benvenuto G; Morrison D K; Lowy D R; DeClue J E
Sequential modification of serines 621 and 624 in the Raf-1 carboxyl terminus produces alterations in its electrophoretic mobility.
The Journal of biological chemistry 1997;272(4):2136-42.
1996: Schiller J T; Lowy D R
Papillomavirus-like particles and HPV vaccine development.
Seminars in cancer biology 1996;7(6):373-82.
1996: Nonnenmacher B; Kruger Kjaer S; Svare E I; Scott J D; Hubbert N L; van den Brule A J; Kirnbauer R; Walboomers J M; Lowy D R; Schiller J T
Seroreactivity to HPV16 virus-like particles as a marker for cervical cancer risk in high-risk populations.
International journal of cancer. Journal international du cancer 1996;68(6):704-9.
1996: Leonardsen L; DeClue J E; Lybaek H; Lowy D R; Willumsen B M
Rasp21 sequences opposite the nucleotide binding pocket are required for GRF-mediated nucleotide release.
Oncogene 1996;13(10):2177-87.
1996: Wideroff L; Schiffman M H; Hoover R; Tarone R E; Nonnenmacher B; Hubbert N; Kirnbauer R; Greer C E; Lorincz A T; Manos M M; Glass A G; Scott D R; Sherman M E; Buckland J; Lowy D; Schiller J
Epidemiologic determinants of seroreactivity to human papillomavirus (HPV) type 16 virus-like particles in cervical HPV-16 DNA-positive and-negative women.
The Journal of infectious diseases 1996;174(5):937-43.
1996: Han C; Qiao G; Hubbert N L; Li L; Sun C; Wang Y; Yan M; Xu D; Li Y; Lowy D R; Schiller J T
Serologic association between human papillomavirus type 16 infection and esophageal cancer in Shaanxi Province, China.
Journal of the National Cancer Institute 1996;88(20):1467-71.
1996: Roden R B; Greenstone H L; Kirnbauer R; Booy F P; Jessie J; Lowy D R; Schiller J T
In vitro generation and type-specific neutralization of a human papillomavirus type 16 virion pseudotype.
Journal of virology 1996;70(9):5875-83.
1996: Roden R B; Hubbert N L; Kirnbauer R; Christensen N D; Lowy D R; Schiller J T
Assessment of the serological relatedness of genital human papillomaviruses by hemagglutination inhibition.
Journal of virology 1996;70(5):3298-301.
1996: Kirnbauer R; Chandrachud L M; O'Neil B W; Wagner E R; Grindlay G J; Armstrong A; McGarvie G M; Schiller J T; Lowy D R; Campo M S
Virus-like particles of bovine papillomavirus type 4 in prophylactic and therapeutic immunization.
Virology 1996;219(1):37-44.
1996: Lowy D R; Schiller J T
Human papillomavirus biology.
Journal of the National Cancer Institute. Monographs 1996;(21):141-3.
1995: Cheng G; Icenogle J P; Kirnbauer R; Hubbert N L; St Louis M E; Han C; Svare E I; Kjaer S K; Lowy D R; Schiller J T
Divergent human papillomavirus type 16 variants are serologically cross-reactive.
The Journal of infectious diseases 1995;172(6):1584-7.
1995: Wideroff L; Schiffman M H; Nonnenmacher B; Hubbert N; Kirnbauer R; Greer C E; Lowy D; Lorincz A T; Manos M M; Glass A G
Evaluation of seroreactivity to human papillomavirus type 16 virus-like particles in an incident case-control study of cervical neoplasia.
The Journal of infectious diseases 1995;172(6):1425-30.
1995: Lowy D R; Willumsen B M
Rational cancer therapy.
Nature medicine 1995;1(8):747-8.
1995: Roden R B; Hubbert N L; Kirnbauer R; Breitburd F; Lowy D R; Schiller J T
Papillomavirus L1 capsids agglutinate mouse erythrocytes through a proteinaceous receptor.
Journal of virology 1995;69(8):5147-51.
1995: Nonnenmacher B; Hubbert N L; Kirnbauer R; Shah K V; Muñoz N; Bosch F X; de Sanjosé S; Viscidi R; Lowy D R; Schiller J T
Serologic response to human papillomavirus type 16 (HPV-16) virus-like particles in HPV-16 DNA-positive invasive cervical cancer and cervical intraepithelial neoplasia grade III patients and controls from Colombia and Spain.
The Journal of infectious diseases 1995;172(1):19-24.
1995: Breitburd F; Kirnbauer R; Hubbert N L; Nonnenmacher B; Trin-Dinh-Desmarquet C; Orth G; Schiller J T; Lowy D R
Immunization with viruslike particles from cottontail rabbit papillomavirus (CRPV) can protect against experimental CRPV infection.
Journal of virology 1995;69(6):3959-63.
1994: Melillo R M; Helin K; Lowy D R; Schiller J T
Positive and negative regulation of cell proliferation by E2F-1: influence of protein level and human papillomavirus oncoproteins.
Molecular and cellular biology 1994;14(12):8241-9.
1994: Roden R B; Kirnbauer R; Jenson A B; Lowy D R; Schiller J T
Interaction of papillomaviruses with the cell surface.
Journal of virology 1994;68(11):7260-6.
1994: Roden R B; Weissinger E M; Henderson D W; Booy F; Kirnbauer R; Mushinski J F; Lowy D R; Schiller J T
Neutralization of bovine papillomavirus by antibodies to L1 and L2 capsid proteins.
Journal of virology 1994;68(11):7570-4.
1994: Kirnbauer R; Hubbert N L; Wheeler C M; Becker T M; Lowy D R; Schiller J T
A virus-like particle enzyme-linked immunosorbent assay detects serum antibodies in a majority of women infected with human papillomavirus type 16.
Journal of the National Cancer Institute 1994;86(7):494-9.
1994: Lowy D R; Kirnbauer R; Schiller J T
Genital human papillomavirus infection.
Proceedings of the National Academy of Sciences of the United States of America 1994;91(7):2436-40.
1994: Johnson M R; DeClue J E; Felzmann S; Vass W C; Xu G; White R; Lowy D R
Neurofibromin can inhibit Ras-dependent growth by a mechanism independent of its GTPase-accelerating function.
Molecular and cellular biology 1994;14(1):641-5.
1993: Cen H; Papageorge A G; Vass W C; Zhang K E; Lowy D R
Regulated and constitutive activity by CDC25Mm (GRF), a Ras-specific exchange factor.
Molecular and cellular biology 1993;13(12):7718-24.
1993: Kirnbauer R; Taub J; Greenstone H; Roden R; Dürst M; Gissmann L; Lowy D R; Schiller J T
Efficient self-assembly of human papillomavirus type 16 L1 and L1-L2 into virus-like particles.
Journal of virology 1993;67(12):6929-36.
1993: DeClue J E; Vass W C; Johnson M R; Stacey D W; Lowy D R
Functional role of GTPase-activating protein in cell transformation by pp60v-src.
Molecular and cellular biology 1993;13(11):6799-809.
1993: Cohen B D; Lowy D R; Schiller J T
The conserved C-terminal domain of the bovine papillomavirus E5 oncoprotein can associate with an alpha-adaptin-like molecule: a possible link between growth factor receptors and viral transformation.
Molecular and cellular biology 1993;13(10):6462-8.
1993: Cohen B D; Goldstein D J; Rutledge L; Vass W C; Lowy D R; Schlegel R; Schiller J T
Transformation-specific interaction of the bovine papillomavirus E5 oncoprotein with the platelet-derived growth factor receptor transmembrane domain and the epidermal growth factor receptor cytoplasmic domain.
Journal of virology 1993;67(9):5303-11.
1993: Johnson M R; Look A T; DeClue J E; Valentine M B; Lowy D R
Inactivation of the NF1 gene in human melanoma and neuroblastoma cell lines without impaired regulation of GTP.Ras.
Proceedings of the National Academy of Sciences of the United States of America 1993;90(12):5539-43.
1993: Ju W D; Schiller J T; Kazempour M K; Lowy D R
TGF alpha enhances locomotion of cultured human keratinocytes.
The Journal of investigative dermatology 1993;100(5):628-32.
1993: Lowy D R; Sedman S A; Cohen B D; Schiller J T
Human papillomaviruses and cancer.
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 1993;128():351-2.
1993: Lowy D R; Willumsen B M
Function and regulation of ras.
Annual review of biochemistry 1993;62():851-91.
1993: Lowy D R; Johnson M R; DeClue J E; Cen H; Zhang K; Papageorge A G; Vass W C; Willumsen B M; Valentine M B; Look A T
Cell transformation by ras and regulation of its protein product.
Ciba Foundation symposium 1993;176():67-80; discussion 80-4.
1992: Kirnbauer R; Booy F; Cheng N; Lowy D R; Schiller J T
Papillomavirus L1 major capsid protein self-assembles into virus-like particles that are highly immunogenic.
Proceedings of the National Academy of Sciences of the United States of America 1992;89(24):12180-4.
1992: Cen H; Papageorge A G; Zippel R; Lowy D R; Zhang K
Isolation of multiple mouse cDNAs with coding homology to Saccharomyces cerevisiae CDC25: identification of a region related to Bcr, Vav, Dbl and CDC24.
The EMBO journal 1992;11(11):4007-15.
1992: Zhang K; Papageorge A G; Lowy D R
Mechanistic aspects of signaling through Ras in NIH 3T3 cells.
Science (New York, N.Y.) 1992;257(5070):671-4.
1992: Sedman S A; Hubbert N L; Vass W C; Lowy D R; Schiller J T
Mutant p53 can substitute for human papillomavirus type 16 E6 in immortalization of human keratinocytes but does not have E6-associated trans-activation or transforming activity.
Journal of virology 1992;66(7):4201-8.
1992: DeClue J E; Papageorge A G; Fletcher J A; Diehl S R; Ratner N; Vass W C; Lowy D R
Abnormal regulation of mammalian p21ras contributes to malignant tumor growth in von Recklinghausen (type 1) neurofibromatosis.
Cell 1992;69(2):265-73.
1991: Zhang K; Papageorge A G; Martin P; Vass W C; Olah Z; Polakis P G; McCormick F; Lowy D R
Heterogeneous amino acids in Ras and Rap1A specifying sensitivity to GAP proteins.
Science (New York, N.Y.) 1991;254(5038):1630-4.
1991: Willumsen B M; Vass W C; Velu T J; Papageorge A G; Schiller J T; Lowy D R
The bovine papillomavirus E5 oncogene can cooperate with ras: identification of p21 amino acids critical for transformation by c-rasH but not v-rasH.
Molecular and cellular biology 1991;11(12):6026-33.
1991: DeClue J E; Cohen B D; Lowy D R
Identification and characterization of the neurofibromatosis type 1 protein product.
Proceedings of the National Academy of Sciences of the United States of America 1991;88(22):9914-8.
1991: Lowy D R; Zhang K; DeClue J E; Willumsen B M
Regulation of p21ras activity.
Trends in genetics : TIG 1991;7(11-12):346-51.
1991: Sedman S A; Barbosa M S; Vass W C; Hubbert N L; Haas J A; Lowy D R; Schiller J T
The full-length E6 protein of human papillomavirus type 16 has transforming and trans-activating activities and cooperates with E7 to immortalize keratinocytes in culture.
Journal of virology 1991;65(9):4860-6.
1991: DeClue J E; Stone J C; Blanchard R A; Papageorge A G; Martin P; Zhang K; Lowy D R
A ras effector domain mutant which is temperature sensitive for cellular transformation: interactions with GTPase-activating protein and NF-1.
Molecular and cellular biology 1991;11(6):3132-8.
1991: DeClue J E; Zhang K; Redford P; Vass W C; Lowy D R
Suppression of src transformation by overexpression of full-length GTPase-activating protein (GAP) or of the GAP C terminus.
Molecular and cellular biology 1991;11(5):2819-25.
1991: Helin K; Velu T; Martin P; Vass W C; Allevato G; Lowy D R; Beguinot L
The biological activity of the human epidermal growth factor receptor is positively regulated by its C-terminal tyrosines.
Oncogene 1991;6(5):825-32.
1991: Ju W D; Velu T J; Vass W C; Papageorge A G; Lowy D R
Tumorigenic transformation of NIH 3T3 cells by the autocrine synthesis of transforming growth factor alpha.
The New biologist 1991;3(4):380-8.
1991: DeClue J E; Vass W C; Papageorge A G; Lowy D R; Willumsen B M
Inhibition of cell growth by lovastatin is independent of ras function.
Cancer research 1991;51(2):712-7.
1991: Barbosa M S; Vass W C; Lowy D R; Schiller J T
In vitro biological activities of the E6 and E7 genes vary among human papillomaviruses of different oncogenic potential.
Journal of virology 1991;65(1):292-8.
1990: Collin C; Papageorge A G; Lowy D R; Alkon D L
Early enhancement of calcium currents by H-ras oncoproteins injected into Hermissenda neurons.
Science (New York, N.Y.) 1990;250(4988):1743-5.
1990: Binétruy B; Schiller J; Lowy D; Cerni C; Cuzin F
Non-selective analysis of the transformation of FR3T3 rat cells by bovine papillomavirus type 1: regulations of viral transcription associated with phenotypic transformation.
Oncogene 1990;5(11):1645-51.
1990: Collin C; Papageorge A G; Sakakibara M; Huddie P L; Lowy D R; Alkon D L
Early regulation of membrane excitability by ras oncogene proteins.
Biophysical journal 1990;58(3):785-90.
1990: Zhang K; DeClue J E; Vass W C; Papageorge A G; McCormick F; Lowy D R
Suppression of c-ras transformation by GTPase-activating protein.
Nature 1990;346(6286):754-6.
1990: Kedar P S; Lowy D R; Widen S G; Wilson S H
Transfected human beta-polymerase promoter contains a ras-responsive element.
Molecular and cellular biology 1990;10(7):3852-6.
1990: Zhang K; Noda M; Vass W C; Papageorge A G; Lowy D R
Identification of small clusters of divergent amino acids that mediate the opposing effects of ras and Krev-1.
Science (New York, N.Y.) 1990;249(4965):162-5.
1990: Cooper K D; Androphy E J; Lowy D; Katz S I
Antigen presentation and T-cell activation in epidermodysplasia verruciformis.
The Journal of investigative dermatology 1990;94(6):769-76.
1990: Barbosa M S; Edmonds C; Fisher C; Schiller J T; Lowy D R; Vousden K H
The region of the HPV E7 oncoprotein homologous to adenovirus E1a and Sv40 large T antigen contains separate domains for Rb binding and casein kinase II phosphorylation.
The EMBO journal 1990;9(1):153-60.
1990: Feldman R A; Lowy D R; Vass W C
Selective potentiation of c-fps/fes transforming activity by a phosphatase inhibitor.
Oncogene research 1990;5(3):187-97.
1989: Feldman R A; Lowy D R; Vass W C; Velu T J
A highly efficient retroviral vector allows detection of the transforming activity of the human c-fps/fes proto-oncogene.
Journal of virology 1989;63(12):5469-74.
1989: Hawley-Nelson P; Vousden K H; Hubbert N L; Lowy D R; Schiller J T
HPV16 E6 and E7 proteins cooperate to immortalize human foreskin keratinocytes.
The EMBO journal 1989;8(12):3905-10.
1989: Lowy D R; Willumsen B M
Protein modification: new clue to Ras lipid glue.
Nature 1989;341(6241):384-5.
1989: Martin P; Vass W C; Schiller J T; Lowy D R; Velu T J
The bovine papillomavirus E5 transforming protein can stimulate the transforming activity of EGF and CSF-1 receptors.
Cell 1989;59(1):21-32.
1989: Sawchuk W S; Weber P J; Lowy D R; Dzubow L M
Infectious papillomavirus in the vapor of warts treated with carbon dioxide laser or electrocoagulation: detection and protection.
Journal of the American Academy of Dermatology 1989;21(1):41-9.
1989: Cerni C; Binétruy B; Schiller J T; Lowy D R; Meneguzzi G; Cuzin F
Successive steps in the process of immortalization identified by transfer of separate bovine papillomavirus genes into rat fibroblasts.
Proceedings of the National Academy of Sciences of the United States of America 1989;86(9):3266-70.
1989: Vousden K H; Androphy E J; Schiller J T; Lowy D R
Mutational analysis of bovine papillomavirus E6 gene.
Journal of virology 1989;63(5):2340-2.
1989: Velu T J; Vass W C; Lowy D R; Beguinot L
Functional heterogeneity of proto-oncogene tyrosine kinases: the C terminus of the human epidermal growth factor receptor facilitates cell proliferation.
Molecular and cellular biology 1989;9(4):1772-8.
1989: Bickers D R; Lowy D R
Carcinogenesis: a fifty-year historical perspective.
The Journal of investigative dermatology 1989;92(4 Suppl):121S-131S.
1989: Schiller J T; Kleiner E; Androphy E J; Lowy D R; Pfister H
Identification of bovine papillomavirus E1 mutants with increased transforming and transcriptional activity.
Journal of virology 1989;63(4):1775-82.
1989: Barbosa M S; Lowy D R; Schiller J T
Papillomavirus polypeptides E6 and E7 are zinc-binding proteins.
Journal of virology 1989;63(3):1404-7.
1989: Velu T J; Vass W C; Lowy D R; Tambourin P E
Harvey murine sarcoma virus: influences of coding and noncoding sequences on cell transformation in vitro and oncogenicity in vivo.
Journal of virology 1989;63(3):1384-92.
1989: Velu T J; Beguinot L; Vass W C; Zhang K; Pastan I; Lowy D R
Retroviruses expressing different levels of the normal epidermal growth factor receptor: biological properties and new bioassay.
Journal of cellular biochemistry 1989;39(2):153-66.
1988: Vousden K H; Doniger J; DiPaolo J A; Lowy D R
The E7 open reading frame of human papillomavirus type 16 encodes a transforming gene.
Oncogene research 1988;3(2):167-75.
1988: Stone J C; Vass W C; Willumsen B M; Lowy D R
p21-ras effector domain mutants constructed by "cassette" mutagenesis.
Molecular and cellular biology 1988;8(8):3565-9.
1988: Hubbert N L; Schiller J T; Lowy D R; Androphy E J
Bovine papilloma virus-transformed cells contain multiple E2 proteins.
Proceedings of the National Academy of Sciences of the United States of America 1988;85(16):5864-8.
1988: Velu T J; Lowy D R
Proto-oncogene activation in lung cancer.
The New England journal of medicine 1988;318(15):992.
1988: Adari H; Lowy D R; Willumsen B M; Der C J; McCormick F
Guanosine triphosphatase activating protein (GAP) interacts with the p21 ras effector binding domain.
Science (New York, N.Y.) 1988;240(4851):518-21.
1988: Hawley-Nelson P; Androphy E J; Lowy D R; Schiller J T
The specific DNA recognition sequence of the bovine papillomavirus E2 protein is an E2-dependent enhancer.
The EMBO journal 1988;7(2):525-31.
1987: Velu T J; Beguinot L; Vass W C; Willingham M C; Merlino G T; Pastan I; Lowy D R
Epidermal-growth-factor-dependent transformation by a human EGF receptor proto-oncogene.
Science (New York, N.Y.) 1987;238(4832):1408-10.
1987: Androphy E J; Hubbert N L; Schiller J T; Lowy D R
Identification of the HPV-16 E6 protein from transformed mouse cells and human cervical carcinoma cell lines.
The EMBO journal 1987;6(4):989-92.
1987: Androphy E J; Lowy D R; Schiller J T
Bovine papillomavirus E2 trans-activating gene product binds to specific sites in papillomavirus DNA.
Nature 1987;325(6099):70-3.
1987: Lowy D R
Potential oncogenic hazards posed by oncogene encoded proteins.
Developments in biological standardization 1987;68():63-7.
1986: Roop D R; Lowy D R; Tambourin P E; Strickland J; Harper J R; Balaschak M; Spangler E F; Yuspa S H
An activated Harvey ras oncogene produces benign tumours on mouse epidermal tissue.
Nature 1986;323(6091):822-4.
1986: Willumsen B M; Papageorge A G; Kung H F; Bekesi E; Robins T; Johnsen M; Vass W C; Lowy D R
Mutational analysis of a ras catalytic domain.
Molecular and cellular biology 1986;6(7):2646-54.
1986: Papageorge A G; Willumsen B M; Johnsen M; Kung H F; Stacey D W; Vass W C; Lowy D R
A transforming ras gene can provide an essential function ordinarily supplied by an endogenous ras gene.
Molecular and cellular biology 1986;6(5):1843-6.
1986: Levitzki A; Rudick J; Pastan I; Vass W C; Lowy D R
Adenylate cyclase activity of NIH 3T3 cells morphologically transformed by ras genes.
FEBS letters 1986;197(1-2):134-8.
1986: Schiller J T; Vass W C; Vousden K H; Lowy D R
E5 open reading frame of bovine papillomavirus type 1 encodes a transforming gene.
Journal of virology 1986;57(1):1-6.
1986: Lowy D R; Willumsen B M
The ras gene family.
Cancer surveys 1986;5(2):275-89.
1985: Lowy D R
Oncogenes are here to stay.
The Journal of investigative dermatology 1985;85(6):495-7.
1985: Willumsen B M; Papageorge A G; Hubbert N; Bekesi E; Kung H F; Lowy D R
Transforming p21 ras protein: flexibility in the major variable region linking the catalytic and membrane-anchoring domains.
The EMBO journal 1985;4(11):2893-6.
1985: Muschel R J; Williams J E; Lowy D R; Liotta L A
Harvey ras induction of metastatic potential depends upon oncogene activation and the type of recipient cell.
The American journal of pathology 1985;121(1):1-8.
1985: Androphy E J; Schiller J T; Lowy D R
Identification of the protein encoded by the E6 transforming gene of bovine papillomavirus.
Science (New York, N.Y.) 1985;230(4724):442-5.
1985: Lowy D R; Schiller J T
Papillomaviruses.
Clinics in dermatology 1985;3(4):1-7.
1985: Androphy E J; Dvoretzky I; Lowy D R
X-linked inheritance of epidermodysplasia verruciformis. Genetic and virologic studies of a kindred.
Archives of dermatology 1985;121(7):864-8.
1985: Kasid A; Lippman M E; Papageorge A G; Lowy D R; Gelmann E P
Transfection of v-rasH DNA into MCF-7 human breast cancer cells bypasses dependence on estrogen for tumorigenicity.
Science (New York, N.Y.) 1985;228(4700):725-8.
1985: DeFeo-Jones D; Tatchell K; Robinson L C; Sigal I S; Vass W C; Lowy D R; Scolnick E M
Mammalian and yeast ras gene products: biological function in their heterologous systems.
Science (New York, N.Y.) 1985;228(4696):179-84.
1984: Schiller J T; Vass W C; Lowy D R
Identification of a second transforming region in bovine papillomavirus DNA.
Proceedings of the National Academy of Sciences of the United States of America 1984;81(24):7880-4.
1984: Epstein W L; Bystryn J C; Edelson R; Elias P M; Lowy D R; Yuspa S
Nonmelanoma skin cancer, melanomas, warts, and viral oncogenesis.
Journal of the American Academy of Dermatology 1984;11(5 Pt 2):960-70.
1984: Willumsen B M; Norris K; Papageorge A G; Hubbert N L; Lowy D R
Harvey murine sarcoma virus p21 ras protein: biological and biochemical significance of the cysteine nearest the carboxy terminus.
The EMBO journal 1984;3(11):2581-5.
1984: Androphy E J; Dvoretzky I; Maluish A E; Wallace H J; Lowy D R
Response of warts in epidermodysplasia verruciformis to treatment with systemic and intralesional alpha interferon.
Journal of the American Academy of Dermatology 1984;11(2 Pt 1):197-202.
1984: Willumsen B M; Christensen A; Hubbert N L; Papageorge A G; Lowy D R
The p21 ras C-terminus is required for transformation and membrane association.
Nature 1984;310(5978):583-6.
1984: Nakabayashi Y; Dvoretzky I; Chattopadhyay S K; Lowy D R
In vitro transformation by bovine papillomavirus.
The Journal of investigative dermatology 1984;83(1 Suppl):12s-17s.
1984: Willumsen B M; Ellis R W; Scolnick E M; Lowy D R
Further genetic localization of the transforming sequences of the p21 v-ras gene of Harvey murine sarcoma virus.
Journal of virology 1984;49(2):601-3.
1984: Androphy E J; Lowy D R
Tumor viruses, oncogenes, and human cancer.
Journal of the American Academy of Dermatology 1984;10(1):125-41.
1983: Nakabayashi Y; Chattopadhyay S K; Lowy D R
The transforming function of bovine papillomavirus DNA.
Proceedings of the National Academy of Sciences of the United States of America 1983;80(19):5832-6.
1983: O'Brien S J; Nash W G; Goodwin J L; Lowy D R; Chang E H
Dispersion of the ras family of transforming genes to four different chromosomes in man.
Nature 1983;302(5911):839-42.
1983: Smyth L D; Lowy D
Auditory vigilance during hypnosis: a brief communication.
The International journal of clinical and experimental hypnosis 1983;31(2):67-71.
1983: Even J; Anderson S J; Hampe A; Galibert F; Lowy D; Khoury G; Sherr C J
Mutant feline sarcoma proviruses containing the viral oncogene (v-fes) and either feline or murine control elements.
Journal of virology 1983;45(3):1004-16.
1983: McCoy M S; Toole J J; Cunningham J M; Chang E H; Lowy D R; Weinberg R A
Characterization of a human colon/lung carcinoma oncogene.
Nature 1983;302(5903):79-81.
1983: Kelly M; Holland C A; Lung M L; Chattopadhyay S K; Lowy D R; Hopkins N H
Nucleotide sequence of the 3' end of MCF 247 murine leukemia virus.
Journal of virology 1983;45(1):291-8.
1982: Turek L P; Byrne J C; Lowy D R; Dvoretzky I; Friedman R M; Howley P M
Interferon induces morphologic reversion with elimination of extrachromosomal viral genomes in bovine papillomavirus-transformed mouse cells.
Proceedings of the National Academy of Sciences of the United States of America 1982;79(24):7914-8.
1982: Papageorge A; Lowy D; Scolnick E M
Comparative biochemical properties of p21 ras molecules coded for by viral and cellular ras genes.
Journal of virology 1982;44(2):509-19.
1982: Tabin C J; Bradley S M; Bargmann C I; Weinberg R A; Papageorge A G; Scolnick E M; Dhar R; Lowy D R; Chang E H
Mechanism of activation of a human oncogene.
Nature 1982;300(5888):143-9.
1982: Dhar R; Ellis R W; Shih T Y; Oroszlan S; Shapiro B; Maizel J; Lowy D; Scolnick E
Nucleotide sequence of the p21 transforming protein of Harvey murine sarcoma virus.
Science (New York, N.Y.) 1982;217(4563):934-6.
1982: Chang E H; Gonda M A; Ellis R W; Scolnick E M; Lowy D R
Human genome contains four genes homologous to transforming genes of Harvey and Kirsten murine sarcoma viruses.
Proceedings of the National Academy of Sciences of the United States of America 1982;79(16):4848-52.
1982: Chang E H; Furth M E; Scolnick E M; Lowy D R
Tumorigenic transformation of mammalian cells induced by a normal human gene homologous to the oncogene of Harvey murine sarcoma virus.
Nature 1982;297(5866):479-83.
1982: Heilman C A; Engel L; Lowy D R; Howley P M
Virus-specific transcription in bovine papillomavirus-transformed mouse cells.
Virology 1982;119(1):22-34.
1982: Chattopadhyay S K; Chang E H; Lander M R; Ellis R W; Scolnick E M; Lowy D R
Amplification and rearrangement of onc genes in mammalian species.
Nature 1982;296(5855):361-3.
1982: Dvoretzky I; Lowy D R
Infections by human papillomavirus (warts).
The American Journal of dermatopathology 1982;4(1):85-9.
1982: Rein A; Lowy D R; Gerwin B I; Ruscetti S K; Bassin R H
Molecular properties of a gag- pol- env+ murine leukemia virus from cultured AKR lymphoma cells.
Journal of virology 1982;41(2):626-34.
1982: Van Beveren C; Rands E; Chattopadhyay S K; Lowy D R; Verma I M
Long terminal repeat of murine retroviral DNAs: sequence analysis, host-proviral junctions, and preintegration site.
Journal of virology 1982;41(2):542-56.
1982: Chattopadhyay S K; Cloyd M W; Linemeyer D L; Lander M R; Rands E; Lowy D R
Cellular origin and role of mink cell focus-forming viruses in murine thymic lymphomas.
Nature 1982;295(5844):25-31.
1981: Chattopadhyay S K; Oliff A I; Linemeyer D L; Lander M R; Lowy D R
Genomes of murine leukemia viruses isolated from wild mice.
Journal of virology 1981;39(3):777-91.
1981: Chattopadhyay S K; Lander M R; Gupta S; Rands E; Lowy D R
Origin of mink cytopathic focus-forming (MCF) viruses:comparison with ecotropic and xenotropic murine leukemia virus genomes.
Virology 1981;113(2):465-83.
1981: Ellis R W; Defeo D; Shih T Y; Gonda M A; Young H A; Tsuchida N; Lowy D R; Scolnick E M
The p21 src genes of Harvey and Kirsten sarcoma viruses originate from divergent members of a family of normal vertebrate genes.
Nature 1981;292(5823):506-11.
1981: DeFeo D; Gonda M A; Young H A; Chang E H; Lowy D R; Scolnick E M; Ellis R W
Analysis of two divergent rat genomic clones homologous to the transforming gene of Harvey murine sarcoma virus.
Proceedings of the National Academy of Sciences of the United States of America 1981;78(6):3328-32.
1981: Law M F; Lowy D R; Dvoretzky I; Howley P M
Mouse cells transformed by bovine papillomavirus contain only extrachromosomal viral DNA sequences.
Proceedings of the National Academy of Sciences of the United States of America 1981;78(5):2727-31.
1981: Rands E; Lowy D R; Lander M R; Chattopadhyay S K
Restriction endonuclease mapping of ecotropic murine leukemia viral DNAs: size and sequence heterogeneity of the long terminal repeat.
Virology 1981;108(2):445-52.
1980: Chang E H; Ellis R W; Scolnick E M; Lowy D R
Transformation by cloned Harvey murine sarcoma virus DNA: efficiency increased by long terminal repeat DNA.
Science (New York, N.Y.) 1980;210(4475):1249-51.
1980: Ellis R W; DeFeo D; Maryak J M; Young H A; Shih T Y; Chang E H; Lowy D R; Scolnick E M
Dual evolutionary origin for the rat genetic sequences of Harvey murine sarcoma virus.
Journal of virology 1980;36(2):408-20.
1980: Chattopadhyay S K; Lander M R; Rands E; Lowy D R
Structure of endogenous murine leukemia virus DNA in mouse genomes.
Proceedings of the National Academy of Sciences of the United States of America 1980;77(10):5774-8.
1980: Oliff A; Linemeyer D; Ruscetti S; Lowe R; Lowy D R; Scolnick E
Subgenomic fragment of molecular cloned Friend murine leukemia virus DNA contains the gene(s) responsible for Friend murine leukemia virus-induced disease.
Journal of virology 1980;35(3):924-36.
1980: Lowy D R; Dvoretzky I; Shober R; Law M F; Engel L; Howley P M
In vitro tumorigenic transformation by a defined sub-genomic fragment of bovine papilloma virus DNA.
Nature 1980;287(5777):72-4.
1980: Wei C M; Lowy D R; Scolnick E M
Mapping of transforming region of the Harvey murine sarcoma virus genome by using insertion-deletion mutants constructed in vitro.
Proceedings of the National Academy of Sciences of the United States of America 1980;77(8):4674-8.
1980: Chang E H; Maryak J M; Wei C M; Shih T Y; Shober R; Cheung H L; Ellis R W; Hager G L; Scolnick E M; Lowy D R
Functional organization of the Harvey murine sarcoma virus genome.
Journal of virology 1980;35(1):76-92.
1980: Dvoretzky I; Shober R; Chattopadhyay S K; Lowy D R
A quantitative in vitro focus assay for bovine papilloma virus.
Virology 1980;103(2):369-75.
1980: Chang H W; Garon C F; Chang E H; Lowy D R; Hager G L; Scolnick E M; Repaske R; Martin M A
Molecular cloning of the Harvey sarcoma virus circular DNA intermediates. II. Further structural analyses.
Journal of virology 1980;33(2):845-55.
1980: Oliff A I; Hager G L; Chang E H; Scolnick E M; Chan H W; Lowy D R
Transfection of molecularly cloned Friend murine leukemia virus DNA yields a highly leukemogenic helper-independent type C virus.
Journal of virology 1980;33(1):475-86.
1980: Lowy D R; Rands E; Chattopadhyay S K; Garon C F; Hager G L
Molecular cloning of infectious integrated murine leukemia virus DNA from infected mouse cells.
Proceedings of the National Academy of Sciences of the United States of America 1980;77(1):614-8.
1980: Scolnick E M; Shih T Y; Maryak J; Ellis R; Chang E; Lowy D
Guanine nucleotide binding activity of the src gene product of rat-derived murine sarcoma viruses.
Annals of the New York Academy of Sciences 1980;354():398-409.
1980: Lowy D R; Rands E; Chattopadhyay S K; Hager G L
Structure and infectivity of integrated murine leukemia virus DNA.
Cold Spring Harbor symposia on quantitative biology 1980;44 Pt 2,():1143-51.
1979: Hager G L; Chang E H; Chan H W; Garon C F; Israel M A; Martin M A; Scolnick E M; Lowy D R
Molecular cloning of the Harvey sarcoma virus closed circular DNA intermediates: initial structural and biological characterization.
Journal of virology 1979;31(3):795-809.
1978: Lowy D R
Infectious murine leukemia virus from DNA of virus-negative AKR mouse embryo cells.
Proceedings of the National Academy of Sciences of the United States of America 1978;75(11):5539-43.
1978: Lowy D R; Rands E; Scolnick E M
Helper-independent transformation by unintegrated Harvey sarcoma virus DNA.
Journal of virology 1978;26(2):291-8.
1978: Lowy D R; Scolnick E M
Glucocorticoids induce focus formation and increase sarcoma viral expression in a mink cell line that contains a murine sarcoma viral genome.
Journal of virology 1978;25(1):157-63.
1978: Howk R S; Troxler D H; Lowy D; Duesberg P H; Scolnick E M
Identification of a 30S RNA with properties of a defective type C virus in murine cells.
Journal of virology 1978;25(1):115-23.
1977: Teich N M; Weiss R A; Martin G R; Lowy D R
Virus infection of murine teratocarcinoma stem cell lines.
Cell 1977;12(4):973-82.
1977: Troxler D H; Lowy D; Howk R; Young H; Scolnick E M
Friend strain of spleen focus-forming virus is a recombinant between ecotropic murine type C virus and the env gene region of xenotropic type C virus.
Proceedings of the National Academy of Sciences of the United States of America 1977;74(10):4671-5.
1975: Chattopadhyay S K; Rowe W P; Teich N M; Lowy D R
Definitive evidence that the murine C-type virus inducing locus Akv-1 is viral genetic material.
Proceedings of the National Academy of Sciences of the United States of America 1975;72(3):906-10.
1975: Chattopadhyay S K; Lowy D R; Teich N M; Levine A S; Rowe W P
Qualitative and quantitative studies of AKR-type murine leukemia virus sequences in mouse DNA.
Cold Spring Harbor symposia on quantitative biology 1975;39 Pt 2():1085-101.
1974: Lowy D R; Teich N M; Chattopadhyay S K
Expression and detection of endogenous mouse C-type RNA viruses.
In vitro 1974;10(5-6):253-9.
1974: Lowy D R; Chattopadhyay S K; Teich N M; Rowe W P; Levine A S
AKR murine leukemia virus genome: frequency of sequences in DNA of high-, low-, and non-virus-yielding mouse strains.
Proceedings of the National Academy of Sciences of the United States of America 1974;71(9):3555-9.
1974: Chattopadhyay S K; Lowy D R; Teich N M; Levine A S; Rowe W P
Evidence that the AKR murine-leukemia-virus genome is complete in DNA of the high-virus AKR mouse and incomplete in the DNA of the "virus-negative" NIH mouse.
Proceedings of the National Academy of Sciences of the United States of America 1974;71(1):167-71.
1973: Pitha P M; Teich N M; Lowy D R; Pitha J
Inhibition of murine leukemia virus replication by poly(vinyluracil) and poly(vinyladenine).
Proceedings of the National Academy of Sciences of the United States of America 1973;70(4):1204-8.
1973: Teich N; Lowy D R; Hartley J W; Rowe W P
Studies of the mechanism of induction of infectious murine leukemia virus from AKR mouse embryo cell lines by 5-iododeoxyuridine and 5-bromodeoxyuridine.
Virology 1973;51(1):163-73.
1972: Lowy D R; Lowy L; Warner R S
A survey of physicians' awareness of drug costs.
Journal of medical education 1972;47(5):349-51.
1972: Rowe W P; Lowy D R; Teich N; Hartley J W
Some implications of the activation of murine leukemia virus by halogenated pyrimidines.
Proceedings of the National Academy of Sciences of the United States of America 1972;69(4):1033-5.
1971: Lowy D R; Rowe W P; Teich N; Hartley J W
Murine leukemia virus: high-frequency activation in vitro by 5-iododeoxyuridine and 5-bromodeoxyuridine.
Science (New York, N.Y.) 1971;174(5):155-6.
1967: Vilcek J; Lowy D R
Interaction of interferon with chick embryo cells.
Archiv für die gesamte Virusforschung 1967;21(2):253-64.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Douglas Lowy

Research Profile (preview)

Living Beings

Anatomy

Chemicals & Drugs

Physiology

Disorders

Genes & Molecular Sequences

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Douglas Lowy (preview)

All Publications